Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?
Status:
Unknown status
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial (a type of research study) designed to describe the efficacy
(effectiveness) and toxicity (safety) of a new medical treatment, NESP (Novel Erythropoiesis
Stimulating Protein). This study will be offered to patients with cervical cancer undergoing
a combination of chemotherapy and radiation. This treatment may lower your red blood cells.
The use of NESP may stimulate the body to produce more red blood cells. Our hypothesis is
that higher red blood cells will be beneficial to the patient during treatment for cervical
cancer.